TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Klerfalk Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
96
|
102
|
160 |
| Financial expenses |
267
|
48
|
304 |
| Earnings before taxes |
15
|
-31
|
665 |
| EBITDA |
7
|
15
|
59 |
| Total assets |
1,055
|
1,046
|
1,184 |
| Current assets |
60
|
109
|
165 |
| Current liabilities |
33
|
42
|
55 |
| Equity capital |
1,012
|
992
|
1,118 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
95.9%
|
94.8%
|
94.4% |
| Turnover per employee |
96
|
102
|
160 |
| Profit as a percentage of turnover |
15.6%
|
-30.4%
|
415.6% |
| Return on assets (ROA) |
26.7%
|
1.6%
|
81.8% |
| Current ratio |
181.8%
|
259.5%
|
300% |
| Return on equity (ROE) |
1.5%
|
-3.1%
|
59.5% |
| Change turnover |
-6
|
-45
|
51 |
| Change turnover % |
-6%
|
-31%
|
47% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.